Patents by Inventor Philip Desmond Hodgkin

Philip Desmond Hodgkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110131028
    Abstract: A cell population process executed by a computer system, the process including generating cell population data representing numbers of cells in a cell population from one or more probability distributions representing probabilities for cell division in the absence of cell death in successive generations of cells of the cell population, and one or more probability distributions representing probabilities for cell death in the absence of cell division in successive generations of cells of the cell population.
    Type: Application
    Filed: November 30, 2007
    Publication date: June 2, 2011
    Inventors: Philip Desmond Hodgkin, Edwin David Hawkins, Marian Linnett Turner, Mark Raymond Dowling, Carel Van Gend, Cameron James Wellard, John Fraser Markham
  • Publication number: 20080060087
    Abstract: In one aspect, the present invention provides a genetically modified cell or non-human organism comprising such cells comprising modified genetic material which when expressed produces a polypeptide co-expressed with a reporter molecule and wherein the polypeptide is associated with terminal differentiation of a haematopoietic cell. Preferably, the genetic material gene is a Blimp allele or a part, fragment or functional form thereof. Furthermore, the identification of the reporter molecule in B-cell lineage cells indicates that such cells are committed to differentiate or have differentiated into ASC. Alternatively, reporter molecule activity in cells of a T cell lineage indicates that these cells are activated. Thus, as described herein, the presence of Blimp in a lymphocyte indicates that the cell is terminally differentiated or is committed to terminal differentiation. Exemplary T-cells include CD4+ T-cells and CD8+ T-cells and exemplary B-cells are ASC.
    Type: Application
    Filed: February 11, 2005
    Publication date: March 6, 2008
    Inventors: Axel Kallies, Jhagvaral Hasbold, David Tarlington, Lynn Corcoran, Philip Desmond Hodgkin, Stephen Laurence Nutt